|
Variables
|
Annual cost of operation ($)
|
Sharing rate (%)
|
# of HCV averted
|
Cost-effectiveness ratio HCV ($)
|
Cost-benefit ratio HCV
|
|---|
|
Post SSF
|
97,203
|
69
|
57
|
1,705
|
20.6
|
| | |
(78, 60)
|
(65, 50)
|
(1,495, 1,944)
|
(23.5, 18.1)
|
|
Two SSF
|
97,203
|
59
|
52
|
3,739
|
18.8
|
| | |
(67, 52)
|
(56, 43)
|
(1,736, 2,261)
|
(20.2,15.5)
|
|
Three SSF
|
97,203
|
58
|
1
|
97,203
|
0.4
|
| | |
(67, 52)
|
(1, 1)
|
(97,203, 97,203)
|
(0.4, 0.4)
|
|
Four SSF
|
97,203
|
58
|
1
|
97,203
|
0.4
|
| | |
(67, 52)
|
(1, 0.5)
|
(97,203, 194,406)
|
(0.4, 0.2)
|
|
Five SSF
|
97,203
|
58
|
1
|
97,203
|
0.4
|
| | |
(67, 52)
|
(1, 0.5)
|
(97,203, 194,406)
|
(0.4, 0.2)
|
|
Six SSF
|
97,203
|
57
|
1
|
97,203
|
0.4
|
| | |
(66, 52)
|
(1, 0.5)
|
(97,203, 194,406)
|
(0.4, 0.2)
|
|
Seven SSF
|
97,203
|
57
|
1
|
97,203
|
0.4
|
| | |
(66, 52)
|
(1, 0.5)
|
(97,203, 194,406)
|
(0.4, 0.2)
|
- The numbers in parentheses represent the results of the sensitivity analysis (90% sharing rate, 70% sharing rate).
